Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Exacctnt who wrote (29310)	6/24/1998 10:53:00 AM
From: Knighty Tin	Read Replies (4) \| Respond to of 132070

Bob, Other than the ones I mention all the time, (GZTC, Genzl, Lgnd, SHMN, etc.) I think that Myriad Genetics (MYGN) has come back to a buying range. And on a "hey, a stock that is actually big enough to buy" basis, Chiron is attractive as all get out. The science there is top-notch. The business plan doesn't exist. <G> But, IMHO, businessmen are easier to find than creative scientists. Just a caveat on that. I thought the same thing, good science, bad business, about Varian in the 1960s. And by the early 1990s, they finally did get their business plan together. So hope this isn't a 2018 starting date for Chiron to get its act in gear. <G> MB